Allogeneic stem cell transplantation in acute myelogenous leukemia
Brinch, L.; Tjønnfjord, G.; Gedde-Dahl, T.; Heldal, D.; Holme, Pål.André.; Dybedal, I.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 128(15): 1681-2; Author Reply 1682
2008
ISSN/ISBN: 0029-2001 PMID: 18704137 Document Number: 618734
Document emailed within 1 workday
Related Documents
Ruiz-Argüelles, G.J.; Gómez-Almaguer, D.; López-Martínez, B.; Cantú-Rodríguez, O.G.; Jaime-Pérez, Jé.C.; González-Llano, O. 2002: Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia Haematologica 87(8): 894-896Ghavamzadeh, A.; Iravani, M.; Jabehdar-Maralani, P.; Hajrasouliha, A.; Tavakoli, S. 2003: Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran Haematologica 88(4): Elt13
Weisser, M.; Tischer, J.; Schnittger, S.; Schoch, C.; Ledderose, G.; Kolb, H.Jochem. 2006: A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation Haematologica 91(5): 663-666
Barrios, M.; Jiménez-Velasco, A.; Román-Gómez, Jé.; Madrigal, Mía.Elena.; Castillejo, J.Antonio.; Torres, A.; Heiniger, A. 2003: Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia Haematologica 88(7): 801-810
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Basak, G.; Torosian, T.; Snarski, E.; Niesiobedzka, J.; Majewski, M.; Gronkowska, A.; Urbanowska, E.; Jedrzejczak, W. 2010: Hematopoietic stem cell transplantation for T315I-mutated chronic myelogenous leukemia Annals of Transplantation 15(2): 68-70
Zikos, P.; Van Lint, M.T.; Lamparelli, T.; Gualandi, F.; Occhini, D.; Bregante, S.; Berisso, G.; Mordini, N.; Incagliato, M.; Fugazza, G.; Sessarego, M.; Bacigalupo, A. 1998: Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse Haematologica 83(10): 896-903
Huang, X.; Wang, F.; Guo, N. 2001: Allogeneic peripheral blood stem cell transplantation for high-risk leukemia Zhonghua Yi Xue Za Zhi 81(22): 1348-1351
Spinelli, O.; Giussani, U.; Borleri, G.; Lazzari, M.; Michelato, A.; Dotti, G.; Barbui, T.; Rambaldi, A. 2000: Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation Haematologica 85(11): 1153-1157
Demirer, T.; Petersen, F.B.; Bensinger, W.I.; Appelbaum, F.R.; Fefer, A.; Rowley, S.; Sanders, J.; Chauncey, T.; Storb, R.; Lilleby, K.; Buckner, C.D. 1996: Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia Bone Marrow Transplantation 18(1): 29-34
Kantarjian, H.M.; Talpaz, M.; Andersson, B.; Khouri, I.; Giralt, S.; Rios, M.B.; Champlin, R.; Hester, J.; Deisseroth, A.B. 1994: High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia Bone Marrow Transplantation 14(1): 57-61
Gómez, M.; Urbano-Ispizua, A.; Cervantes, F.; Fernández-Avilés, F.; Rovira, M.; Carreras, E. 2002: Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation Haematologica 87(9): 1003-1005
Zittoun, R.; Mandelli, F.; Willemze, R.; de Witte, T.; Tura, S.; Ferrini, P.R.; Stryckmans, P.; Gattringer, C.; Petti, M.C.; Solbu, G. 1992: Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase IIi trial (AML8 A). the EORTC Leukemia Cooperative Group and the GIMEMA Group Leukemia 6(Suppl 2): 114-115
Lin, Y.T.; Lin, D.T.; Jou, S.T.; Lin, K.S.; Lin, K.H. 1997: Allogeneic bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in childhood Journal of the Formosan Medical Association 96(5): 320-324
Jurado, M.; Delgado, C.; Moratalla, A.; Casero, D.; Oyonarte, S.; de Pablos, J.M. 1996: Use of rhG-CSF in the collection of peripheral blood stem cells for autologous blood stem cell transplantation in acute myeloblastic leukemia Bone Marrow Transplantation 18(4): 821-822
Kanda, Y. 2012: Chemotherapy and hematopoietic stem cell transplantation for acute lymphoblastic leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 447-455
Mengarelli, A.; Iori, A.Paola.; Cerretti, R.; Cerilli, L.; Romano, A.; Arcese, W. 2002: Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy Haematologica 87(7): 782-784
Chen, Y.; Xu, L-ping.; Liu, D-hong.; Chen, Y-hong.; Han, W.; Shi, H-xia.; Zhang, X-hui.; Wang, J-zhi.; Chen, H.; Liu, K-yan.; Huang, X-jun.; Lu, D-pei. 2007: Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation Zhonghua Yi Xue Za Zhi 87(14): 964-966
Drobyski, W.R.; Roth, M.S.; Thibodeau, S.N.; Gottschall, J.L. 1992: Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Bone Marrow Transplantation 10(3): 301-304
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596